1. Home
  2. TLRY

as of 12-31-2025 3:38pm EST

$9.00
$0.06
-0.61%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: NEW YORK
Market Cap: 1.2B IPO Year: 2018
Target Price: $150.00 AVG Volume (30 days): 20.0M
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -23.02 EPS Growth: N/A
52 Week Low/High: $3.51 - $23.20 Next Earning Date: 01-08-2026
Revenue: $830,766,000 Revenue Growth: 2.31%
Revenue Growth (this year): 7.28% Revenue Growth (next year): 4.51%

AI-Powered TLRY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 73.58%
73.58%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Tilray Brands Inc. News

TLRY Breaking Stock News: Dive into TLRY Ticker-Specific Updates for Smart Investing

All TLRY News

Share on Social Networks: